SubHero Banner
Text

Xyzal® Allergy 24HR (levocetirizine) products – Rx-to-OTC approval

February 1, 2017 – Sanofi announced the FDA approval of Xyzal Allergy 24HR (levocetirizine) tablets and Children’s Xyzal Allergy 24HR oral solution, as an over-the-counter (OTC) treatment to temporarily relieve symptoms of runny nose, sneezing, itchy and watery eyes, and itching of the nose or throat due to hay fever or other respiratory allergies.

Download PDF